Myriam Curet Sells 5,318 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 5,318 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total value of $1,971,169.88. Following the completion of the transaction, the executive vice president now owns 298 shares in the company, valued at approximately $110,456.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Myriam Curet also recently made the following trade(s):

• On Friday, March 1st, Myriam Curet sold 1,605 shares of Intuitive Surgical stock. The shares were sold at an average price of $383.48, for a total value of $615,485.40.
• On Monday, February 12th, Myriam Curet sold 481 shares of Intuitive Surgical stock. The shares were sold at an average price of $386.09, for a total value of $185,709.29.
• On Friday, January 26th, Myriam Curet sold 4,318 shares of Intuitive Surgical stock. The shares were sold at an average price of $370.15, for a total value of $1,598,307.70.

Intuitive Surgical Stock Performance

ISRG stock opened at $375.01 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76. The stock’s 50 day moving average price is $386.40 and its 200 day moving average price is $345.19. The firm has a market cap of $133.02 billion, a P/E ratio of 67.69, a PEG ratio of 4.83 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter in the prior year, the company earned $1.00 EPS. Intuitive Surgical’s revenue was up 11.5% on a year-over-year basis. On average, research analysts predict that Intuitive Surgical, Inc. will post 4.84 earnings per share for the current year.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently bought and sold shares of the stock. Cambridge Investment Research Advisors Inc. lifted its stake in shares of Intuitive Surgical by 24.9% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 32,933 shares of the medical equipment provider’s stock worth $13,143,000 after purchasing an additional 6,570 shares during the period. Elite Wealth Management Inc. boosted its holdings in shares of Intuitive Surgical by 10.1% during the first quarter. Elite Wealth Management Inc. now owns 24,294 shares of the medical equipment provider’s stock worth $9,695,000 after purchasing an additional 2,230 shares during the last quarter. Leavell Investment Management Inc. boosted its holdings in shares of Intuitive Surgical by 3.8% during the first quarter. Leavell Investment Management Inc. now owns 3,014 shares of the medical equipment provider’s stock worth $1,203,000 after purchasing an additional 109 shares during the last quarter. CENTRAL TRUST Co boosted its holdings in shares of Intuitive Surgical by 7.0% during the first quarter. CENTRAL TRUST Co now owns 2,339 shares of the medical equipment provider’s stock worth $933,000 after purchasing an additional 154 shares during the last quarter. Finally, V Square Quantitative Management LLC boosted its holdings in shares of Intuitive Surgical by 58.8% during the first quarter. V Square Quantitative Management LLC now owns 3,820 shares of the medical equipment provider’s stock worth $1,525,000 after purchasing an additional 1,414 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. StockNews.com cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Piper Sandler boosted their target price on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research report on Friday, April 19th. Robert W. Baird dropped their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday, April 19th. Barclays boosted their target price on Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research report on Thursday, January 25th. Finally, BTIG Research boosted their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.